Pharmaceutical

BGBA-3055 by BeiGene for Solid Tumor: Likelihood of Approval

BGBA-3055 is under clinical development by BeiGene and currently in Phase I for Solid Tumor.

Oct 3, 2023 - 20:00
BGBA-3055 is under clinical development by BeiGene and currently in Phase I for Solid Tumor.
Read the original article

Tags:

Previous Article

BGB-26808 by BeiGene for Solid Tumor: Likelihood of Approval

Next Article

BW-20507 by Argo Biopharma Australia for Hepatitis B: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Novo Nordisk spent $11 million on doctors to promote Ozempic and similar drugs; China offers foreign drugmakers an olive branch

STAT+: Pharmalittle: Novo Nordisk spent $11 million on ...

Jul 6, 2023

FDA denies approval for Astellas’ investigational gastric cancer drug

FDA denies approval for Astellas’ investigational gastr...

Jan 9, 2024

STAT+: A new lobby shop looks to remind Congress about NIH’s translational research arm

STAT+: A new lobby shop looks to remind Congress about ...

Jul 24, 2023